The Cannabis Alliance

Lawmaker questions focused on potential risks and negative outcomes during mostly supportive testimony on 2024 cannabis home growing legislation.

Some legislators seemed eager to at least appear to be eager to earmark unapportioned cannabis excise tax revenue at the beginning of the third week of the 2024 regular session.

After a brisk week of cannabis policy committee activity in the House including consideration of several controversial bills, legislators were scheduled to address other topics until Monday.

A new bill to raise the age limit on cannabis concentrates and require additional educational resources received support from prevention groups but opposition from cannabis stakeholders.

Legislation to alter a planned transfer of cannabis lab accreditation authority was broadly praised by the sponsor, agency leaders, and cannabis sector stakeholders. 

By the end of Tuesday, Representatives tasked with oversight of the adult-use cannabis market were scheduled to have heard five bills and considered moving two in the first days of the week.

A bill to make cannabis business bans the purview of voters rather than their elected officials drew pushback from local government interests and support from an industry stakeholder.

Cannabis waste legislation was advanced, another hemp bill may be on the way, the first cannabis-related bills were heard, and two new bills were scheduled for introduction.

Organization leaders and attendees heard from two prominent legislators on long-running cannabis topics and expected priorities for the 2024 regular legislative session.

DOH staff heard stories and suggestions from patients, advocates, and other stakeholders on how to improve affordability, access, and understanding of medically compliant cannabis products.